BLTEBelite Bio, Inc
$154.26+120% 1Y
$154.26
$69.8052 weeks$193.66
BLTE as reported
- Net income
- −$78M
Net income · +115% year on year · trailing twelve months to FY2025
- Free cash flow
- −$37M
Free cash flow · +26% year on year · trailing twelve months to FY2025
- EPS
- −$2.31
EPS · +96% year on year · trailing twelve months to FY2025
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$78M | +115% | FY2025 |
| EPS | −$2.31 | +96% | FY2025 |
| ROE | −10% | n/a | FY2025 |
| ROA | −9.9% | n/a | FY2025 |
| Free cash flow | −$37M | +26% | FY2025 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Belite Bio, Inc (BLTE) · Net incomeNet incomeBelite Bio, Inc (BLTE)